Nanotechnology Now

Our NanoNews Digest Sponsors

Heifer International

Wikipedia Affiliate Button

Home > Press > Nanoparticles Mimic Cholesterol Transporter and Attack Lymphoma

Abstract:
High-density lipoprotein (HDL) is well-known for its role in protecting the body from developing coronary artery disease, but HDL also helps lymphomas and other cancers acquire the large amounts of cholesterol they need to maintain the structure of their cell membranes as they grow rapidly. Researchers at Northwestern University have taken advantage of this dependency on HDL to create an HDL-mimicking nanoparticle that starves lymphoma cells of cholesterol, triggering them to commit programmed cell death without the use of any other anticancer agent.

Nanoparticles Mimic Cholesterol Transporter and Attack Lymphoma

Bethesda, MD | Posted on March 7th, 2013

C. Shad Thaxton, of the Robert H. Lurie Comprehensive Cancer Center at Northwestern and member of the Northwestern University Center of Cancer Nanotechnology Excellence, and Leo Gordon, of Northwestern's Feinberg School of Medicine, led the team that developed this biomimetic HDL nanostructure. The investigators published their findings in the Proceedings of the National Academy of Sciences.

To create their biomimetic HDL nanostructures, the researchers start with spherical gold nanoparticles that are five nanometers in diameter and add the human protein ApoA1 and two phospholipids found in native HDLs. The gold nanoparticle serves two functions. First, it acts as a template that controls the shape and size of the biomimetic particles so that they recognize and bind tightly to a specific receptor, known as scavenger receptor type B-1 (SR-B1), which is expressed by lymphoma cells. Second, the gold core occupies the space that is normally filled by cholesterol esters, which thereby limits the ability of these particles to deliver cholesterol to the receptor-targeted lymphoma cells.

Initial experiments with lymphoma cells growing in culture showed that these nanoparticles are taken up by cells that have the target (SR-B1) receptor and have the desired effect of triggering programmed cell death, also known as apoptosis. They also demonstrated that apoptosis resulted from cholesterol flowing out of the cells. In contrast, the biomimetic HDL nanoparticles did not trigger cholesterol outflow from or apoptosis in normal human liver cells, macrophages, or lymphocytes.

Drs. Thaxton and Gordon and their collaborators then treated mice with human lymphomas with the biomimetic HDL nanoparticles. This treatment stopped tumor growth when the tumors were derived from lymphoma cells that expressed SR-B1, but had no effect on tumors derived from SR-B1 negative cells. The researchers note that because SR-B1 is not expressed in the majority of human tissue that the toxicity of these nanoparticles may be minimal compared to conventional chemotherapeutics.

####

About The National Cancer Institute (NCI)
To help meet the goal of reducing the burden of cancer, the National Cancer Institute (NCI), part of the National Institutes of Health, is engaged in efforts to harness the power of nanotechnology to radically change the way we diagnose, treat and prevent cancer.

The NCI Alliance for Nanotechnology in Cancer is a comprehensive, systematized initiative encompassing the public and private sectors, designed to accelerate the application of the best capabilities of nanotechnology to cancer.

Currently, scientists are limited in their ability to turn promising molecular discoveries into benefits for cancer patients. Nanotechnology can provide the technical power and tools that will enable those developing new diagnostics, therapeutics, and preventives to keep pace with todays explosion in knowledge.

For more information, please click here

Contacts:
National Cancer Institute
Office of Technology & Industrial Relations
ATTN: NCI Alliance for Nanotechnology in Cancer
Building 31, Room 10A49
31 Center Drive , MSC 2580
Bethesda , MD 20892-2580

Copyright © The National Cancer Institute (NCI)

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Bookmark:
Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related Links

View abstract - "Biomimetic, synthetic HDL nanostructures for lymphoma."

Related News Press

News and information

ATTOPSEMI Technology Joins FDXcelerator Program to Deliver Advanced Non-Volatile Memory IP to GLOBALFOUNDRIES 22 FDX Technology Platform: Leading-edge I-fuse brings higher reliability, smaller cell size and ease of programmability for consumer, automotive, and IoT applications March 27th, 2017

Leti and HORIBA Scientific to Host Webinar on Ultrafast Characterization Tool: Plasma Profiling Time-of-Flight Mass Spectrometer Tool Cuts Optimization Time In Layer Deposition and Fabrication of Wide Range of Applications March 27th, 2017

Laser activated gold pyramids could deliver drugs, DNA into cells without harm: Microstructures create temporary pores in cells March 27th, 2017

Researchers make flexible glass for tiny medical devices: Glass can bend over and over again on a nanoscale March 27th, 2017

Govt.-Legislation/Regulation/Funding/Policy

Laser activated gold pyramids could deliver drugs, DNA into cells without harm: Microstructures create temporary pores in cells March 27th, 2017

Cryo-electron microscopy achieves unprecedented resolution using new computational methods March 25th, 2017

Argon is not the 'dope' for metallic hydrogen March 24th, 2017

Artificial photosynthesis steps into the light: Rice University lab turns transition metals into practical catalyst for solar, other applications March 23rd, 2017

Nanomedicine

Laser activated gold pyramids could deliver drugs, DNA into cells without harm: Microstructures create temporary pores in cells March 27th, 2017

Researchers make flexible glass for tiny medical devices: Glass can bend over and over again on a nanoscale March 27th, 2017

Cryo-electron microscopy achieves unprecedented resolution using new computational methods March 25th, 2017

Nanobiotix: The Independent Data Monitoring Committee Recommends the Continuation of the Ongoing Phase II/III Trial of NBTXR3 in Soft Tissue Sarcoma March 23rd, 2017

Discoveries

Laser activated gold pyramids could deliver drugs, DNA into cells without harm: Microstructures create temporary pores in cells March 27th, 2017

Researchers make flexible glass for tiny medical devices: Glass can bend over and over again on a nanoscale March 27th, 2017

Cryo-electron microscopy achieves unprecedented resolution using new computational methods March 25th, 2017

Argon is not the 'dope' for metallic hydrogen March 24th, 2017

Announcements

ATTOPSEMI Technology Joins FDXcelerator Program to Deliver Advanced Non-Volatile Memory IP to GLOBALFOUNDRIES 22 FDX Technology Platform: Leading-edge I-fuse brings higher reliability, smaller cell size and ease of programmability for consumer, automotive, and IoT applications March 27th, 2017

Leti and HORIBA Scientific to Host Webinar on Ultrafast Characterization Tool: Plasma Profiling Time-of-Flight Mass Spectrometer Tool Cuts Optimization Time In Layer Deposition and Fabrication of Wide Range of Applications March 27th, 2017

Laser activated gold pyramids could deliver drugs, DNA into cells without harm: Microstructures create temporary pores in cells March 27th, 2017

Researchers make flexible glass for tiny medical devices: Glass can bend over and over again on a nanoscale March 27th, 2017

NanoNews-Digest
The latest news from around the world, FREE



  Premium Products
NanoNews-Custom
Only the news you want to read!
 Learn More
NanoTech-Transfer
University Technology Transfer & Patents
 Learn More
NanoStrategies
Full-service, expert consulting
 Learn More











ASP
Nanotechnology Now Featured Books




NNN

The Hunger Project